NASDAQ · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · MID CAP
Orthofix Medical Inc. OFIX
17 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$822.3M
▲ 2.9% vs FY2024
EPS · FY25
$-2.33
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-19.3%
Net margin · FY25
-11.2%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 822.3M
Revenue, FY2025 · full 17-year series below
Revenue
Net income
The company lost 11 cents on every revenue dollar this year.
Per share
USD -2.33
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-19.3%
Return on equity, FY2025
ROE
Operating margin-9.9%
Net margin-11.2%
Return on assets-10.6%
Each USD of equity lost 19 cents this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
+15.1% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+21.3%
+15.1%
+7.6%
+3.9%
Returned to shareholders
+6.6%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.04B
Shares outstanding, FY2025
Change, 5 years+10.3%
Change, 10 years+4.3%
The share count grew 10% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 850.6M
total assets, end of FY2025
Total assetsUSD 850.6M
EquityUSD 450.0M
CashUSD 82.0M
Gross debtUSD 157.4M
Net debtUSD 75.4M
Current ratio2.45×
Net debt stands at 17% of equity.
History
17 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
Revenue $B
0.8
0.8
0.7
0.5
0.5
0.4
0.5
0.5
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.5
0.5
Operating income $B
−0.1
−0.1
−0.1
−0.0
−0.0
−0.0
−0.0
0.0
0.0
0.0
0.0
0.0
−0.0
0.1
0.0
0.1
0.1
EBITDA $B
−0.0
−0.0
−0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.1
0.1
Income tax $B
0.0
0.0
0.0
0.0
0.0
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
−0.0
0.0
Net income $B
−0.1
−0.1
−0.2
−0.0
−0.0
0.0
−0.0
0.0
0.0
0.0
−0.0
−0.0
−0.0
0.0
−0.0
0.0
0.0
EPS, diluted $
−2.33
−3.30
−4.12
−0.98
−1.95
0.13
−1.51
0.72
0.34
0.17
−0.15
−0.46
−1.54
2.21
−0.97
2.47
1.42
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
−19.3
−22.9
−32.4
−5.9
−11.1
0.7
−8.6
4.4
2.2
1.1
−1.0
−2.9
−8.8
13.5
−6.1
16.4
10.2
Shares out B
0.04
0.04
0.04
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
66 of 66
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed